AGL: agilon health, inc. Stock

SIC 809 – Miscellaneous Health And Allied Services, Not

Valuation
Market Cap ($M) 1,273.14
Enterprise Value ($M) 1,167.84
Book Value ($M) 574.87
Book Value / Share 1.40
Price / Book 2.21
NCAV ($M) 295.22
NCAV / Share 0.72
Price / NCAV 4.31

Profitability (mra)
Return on Invested Capital (ROIC) -0.61
Return on Assets (ROA) -0.22
Return on Equity (ROE) -0.58

Liquidity (mrq)
Quick Ratio 1.29
Current Ratio 1.29

Balance Sheet (mrq) ($M)
Current Assets 1,811.76
Assets 2,091.41
Liabilities 1,516.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-13 13G/A Capital World Investors 11.80 -12.41
11-08 13G/A Wellington Management Group Llp 12.85 24.40
11-08 13G BlackRock, Inc. 5.80 0.00
11-06 13G/A Morgan Stanley 13.40 26.13
09-10 13G/A Fmr Llc 6.84 -53.68
02-13 13G Vanguard Group Inc 7.04
02-08 13G/A CD&R Vector Holdings, L.P. 24.60 -48.62

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-21 2,344,689 7,187,786 32.62
2025-01-17 2,244,556 7,257,482 30.93
2025-01-16 2,468,605 9,285,812 26.58

(click for more detail)

Similar Companies
DVA – DaVita Inc.


Financial data and stock pages provided by
Fintel.io